Posted in | News

The First Commercially Available Betavoltaic Product - NanoTritium from City Labs

City Labs, Inc., the pioneering innovator of long-life (20+ years) NanoTritium betavoltaic power sources for microelectronics, has released its first commercial product, a tritium-based betavoltaic power source that enables low-power microelectronic and sensor applications where battery replacement is difficult, impossible, or life-threatening.

The Model P100a betavoltaic power source provides a source of continuous nanoWatt power for twenty years or more in microelectronic platforms. Applications include: environmental pressure/temperature sensors, intelligence sensors, medical implants, trickle charging lithium batteries, semi-passive and active RFID tags, silicon clocks, SRAM memory backup, deep-sea oil well electronics, lower power processors (e.g. ASICs, FPGAs, MicroController Units, etc.). As tested and confirmed by Lockheed Martin, the City Labs NanoTritiumTM betavoltaic is able to resist broad temperature extremes where traditional lithium batteries are subject to failure. Lockheed Martin tested previous versions of these newly available commercial power sources; they were found to be resistant to extreme temperatures (-50°C to +150°C), as well as extreme vibration and altitude.

City Labs is the first company in the betavoltaic battery industry to be granted a Product Regulatory General License to manufacture, sell, and distribute its NanoTritium betavoltaic power sources. These devices contain small amounts of tritium, a radioisotope commonly found in Exit signs and diver's watches. The General License provides the end-user with a safe, reliable and commercially available betavoltaic power source, and eliminates both the burden of regulatory paperwork and end-user radiological training. The General License also allows for easy purchase of the betavoltaic power source without requiring the customer to have a prior radiation license.

Last year, City Labs announced completion of its first round of financing and a million-dollar contract awarded by the United States Air Force.

About City Labs, Inc.

City Labs, Inc., a minority-owned startup company based in South Florida, is the innovator and manufacturer of long-life, energy harvesting NanoTritium betavoltaic power sources for microelectronics, sensors and other small devices used in defense, homeland security and medical implants. Founded in 2005, the company's team of scientists and engineers has developed a betavoltaic power source with a lifetime of 20+ years without requiring replenishment; betavoltaics can power a range of devices where battery replacement is difficult or impossible. City Labs' betavoltaic power source is resistant to varying temperatures and other environmental conditions due to the fact that it is based on the decay of tritium, a radioisotope used as an illumination source for Exit signs commonly found in schools, theatres, commercial buildings, and aircraft.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    City Labs, Inc.. (2019, February 09). The First Commercially Available Betavoltaic Product - NanoTritium from City Labs. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=33362.

  • MLA

    City Labs, Inc.. "The First Commercially Available Betavoltaic Product - NanoTritium from City Labs". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=33362>.

  • Chicago

    City Labs, Inc.. "The First Commercially Available Betavoltaic Product - NanoTritium from City Labs". AZoM. https://www.azom.com/news.aspx?newsID=33362. (accessed November 21, 2024).

  • Harvard

    City Labs, Inc.. 2019. The First Commercially Available Betavoltaic Product - NanoTritium from City Labs. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=33362.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.